THBS1+ Macrophages Exacerbate Modic Changes via SDC4-Dependent Activation of NLRP3 Inflammasome

Xiangxi Kong1,2, Qize Xue3, Xiaoan Wei1,2

  • 1Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China.

Insights

Pro-inflammatory THBS1+ macrophages drive Modic changes (MCs) in the spine. Targeting THBS1 and SDC4 may offer new treatments for low back pain and disc degeneration.

Area of Science:

  • Immunology
  • Orthopedics
  • Cell Biology

Background:

  • Modic changes (MCs) are common in low back pain and linked to immune responses.
  • Understanding the immune microenvironment is crucial for MCs pathogenesis.

Purpose of the Study:

  • To investigate the immunomodulatory mechanisms driving lumbar Modic changes.
  • To identify key molecular players in MCs progression.

Main Methods:

  • Analysis of human MCs specimens and a C. acnes-induced mouse model.
  • In vitro studies on macrophage and chondrocyte responses to C. acnes.
  • Investigated THBS1, SDC4, TLR, and NLRP3 inflammasome involvement.
  • Utilized conditional knockout and gene silencing techniques.

Main Results:

  • THBS1+ macrophages with a pro-inflammatory phenotype are enriched at MC lesion sites.
  • C. acnes promotes THBS1 expression in macrophages via TLR signaling.
  • THBS1-SDC4 interaction on chondrocytes activates p38 and the NLRP3 inflammasome.
  • Targeting THBS1 or SDC4 attenuated MCs progression in vitro and in vivo.

Conclusions:

  • THBS1+ macrophages exacerbate lumbar endplate MCs via the SDC4-p38-NLRP3 pathway.
  • THBS1 and SDC4 are potential immunotherapeutic targets for disc degeneration.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammation01:38

Inflammation

Overview